OncoSec Medical Inc (ONCS)

2.21 +0.07  +3.27% NASDAQ Dec 5, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All ONCS News


View All Events


Date Type Description
10/24/2019 Earnings OncoSec Medical Inc Fourth Quarter Earnings Results for 2019
06/14/2019 Earnings OncoSec Medical Inc Third Quarter Earnings Results in 2019
05/21/2019 Splits Ratio: 1:10
03/08/2019 Earnings OncoSec Medical Inc Second Quarter Earnings Results in 2019
12/18/2018 10:00 EST Misc OncoSec Medical Inc Annual General Meeting in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL: http://www.oncosec.com
  • Investor Relations URL: N/A
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: N/A
  • Last Earnings Release: Oct. 24, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.